267 related articles for article (PubMed ID: 32318767)
1. Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer : Results from a phase II trial.
Meng J; Huang W; Mei X; Yu X; Pan Z; Ma J; Ma X; Chen J; Guo X; Yang Z
Strahlenther Onkol; 2020 Sep; 196(9):764-770. PubMed ID: 32318767
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.
De Rose F; Fogliata A; Franceschini D; Navarria P; Villa E; Iftode C; D'Agostino G; Cozzi L; Lobefalo F; Mancosu P; Tomatis S; Scorsetti M
Radiat Oncol; 2016 Sep; 11(1):120. PubMed ID: 27639373
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.
De Rose F; Fogliata A; Franceschini D; Iftode C; Torrisi R; Masci G; Sagona A; Tinterri C; Testori A; Gatzemeier W; Fernandes B; Rahal D; Cozzi L; Santoro A; Scorsetti M
Br J Radiol; 2018 May; 91(1085):20170634. PubMed ID: 29322827
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
[TBL] [Abstract][Full Text] [Related]
6. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost.
McDonald MW; Godette KD; Whitaker DJ; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):523-30. PubMed ID: 19775834
[TBL] [Abstract][Full Text] [Related]
7. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
8. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial.
Liss AL; Ben-David MA; Jagsi R; Hayman JA; Griffith KA; Moran JM; Marsh RB; Pierce LJ
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):96-102. PubMed ID: 24613813
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients.
Fiorentino A; Mazzola R; Giaj Levra N; Fersino S; Ricchetti F; Di Paola G; Gori S; Massocco A; Alongi F
Aging Clin Exp Res; 2018 May; 30(5):533-538. PubMed ID: 28755327
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
[TBL] [Abstract][Full Text] [Related]
12. Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).
Hörner-Rieber J; Forster T; Hommertgen A; Haefner MF; Arians N; König L; Harrabi SB; Schlampp I; Weykamp F; Lischalk JW; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Hof H; Krug D; Debus J
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1311-1324. PubMed ID: 33321192
[TBL] [Abstract][Full Text] [Related]
13. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
[TBL] [Abstract][Full Text] [Related]
14. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
19. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
[TBL] [Abstract][Full Text] [Related]
20. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]